C-peptide: what your result means.

A byproduct of insulin production; reflects how much insulin the pancreas makes. C-peptide is measured by blood test as part of the Metabolic panel in the HodieLabs Health Blueprint.

Why C-peptide matters

Useful adjunct when fasting insulin is equivocal; interpret with glucose/insulin. Interpret using the reporting lab’s reference interval and clinical context; trend over time is often more informative than a single value.

Associated risks when out of range: Hyperinsulinaemia confirmation, Beta-cell stress (contextual).

Evidence basis

The HodieLabs Evidence-Based Clinical Library classifies C-peptide as an strong evidence-tier biomarker. Its reference ranges come from a published authority standard rather than from observational optimisation targets. The standard used here is RCPA-accredited Australian pathology lab reference interval; fasting C-peptide 0.3–1.5 nmol/L. Consistent with Endocrine Society guidelines (0.37–1.47 nmol/L), rounded to the lab-reported range that patients and clinicians see on pathology results. Where relevant clinical outcomes are noted on this page, they reflect the guideline literature referenced below.

Evidence-based reference ranges

The HodieLabs Evidence-Based Clinical Library interprets C-peptide against published clinical authority standards, never arbitrary "optimal" ranges. Measured in nmol/L (lab dependent):

Clinical interpretation

• Useful adjunct when fasting insulin is equivocal; interpret with glucose/insulin.
• Interpret using the reporting lab’s reference interval and clinical context; trend over time is often more informative than a single value.

What improves it: the evidence-based levers

• Investigate pancreatic beta-cell function if abnormal
• Correlate with insulin levels to distinguish insulin resistance from beta-cell failure

Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.

How C-peptide testing works at HodieLabs

C-peptide is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.

References

1. RCPA-accredited Australian pathology lab reference interval; fasting C-peptide 0.3–1.5 nmol/L. Consistent with Endocrine Society guidelines (0.37–1.47 nmol/L), rounded to the lab-reported range that patients and clinicians see on pathology results.

This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.